Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast - 2023 -United States" drug pipelines to their offering.
The US market size of Cytomegalovirus (CMV) infection shall reach to USD 609.88 Million by the end of 2023. The market size for Prophylaxis is expected to grow at a CAGR of 3.71% from 2013-2023, while the sales for the therapeutic shall increase at a CAGR of 3.55% from the year 2013-2023. As per estimation, the US Prophylaxis market is relatively higher than the therapeutic market.
United States Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast 2023 provides an overview of the disease and market size of the CMV for United States. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.
As per estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023.
Key Topics Covered:
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/wr8tt4/cytomegalovirus
View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005520/en/Business Wire
Last updated on: 17/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.